Related Experiment Video
Updated: Jul 10, 2026

Visualization and Quantitative Analysis of Genotoxin-Induced PARP1/PARP2 Activation in Cells Using a Fluorescent Fusion Protein-Based Reporter
Published on: April 17, 2026
Gene transactivation without direct DNA binding defines a novel gain-of-function for PML-RARalpha
Sake van Wageningen1, Marleen C Breems-de Ridder, Jeannet Nigten
1Central Hematology Laboratory and Department of Hematology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Abstract:
PML-RARalpha is the causative oncogene in 5% to 10% of the cases of acute myeloid leukemia. At physiological concentrations of retinoic acid, PML-RARalpha silences RARalpha target genes, blocking differentiation of the cells. At high concentrations of ligand, it (re)activates the transcription of target genes, forcing terminal differentiation. The study of RARalpha target genes that mediate this differentiation has identified several genes that are important for proliferation and differentiation control in normal and malignant hematopoietic cells. In this paper, we show that the PML-RARalpha fusion protein not only interferes with the transcription of regular RARalpha target genes. We show that the ID1 and ID2 promoters are activated by PML-RARalpha but, unexpectedly, not by wild-type RARalpha/RXR. Our data support a model in which the PML-RARalpha fusion protein regulates a novel class of target genes by interaction with the Sp1 and NF-Y transcription factors, without directly binding to the DNA, defining a gain-of-function for the oncoprotein.
Insights
The PML-RARalpha oncoprotein in acute myeloid leukemia silences gene differentiation. Unexpectedly, it activates ID1 and ID2 genes via transcription factors, revealing a novel gain-of-function mechanism.
Area of Science:
- Oncology
- Molecular Biology
- Hematopoiesis
Background:
- PML-RARalpha is a key oncogene in acute myeloid leukemia (AML), driving disease by disrupting normal cellular differentiation.
- Retinoic acid (RA) regulates PML-RARalpha activity: low RA causes gene silencing and blocks differentiation, while high RA forces terminal differentiation.
- Understanding RARalpha target genes is crucial for controlling hematopoietic cell proliferation and differentiation in both normal and malignant states.
Purpose of the Study:
- To investigate the transcriptional regulatory role of the PML-RARalpha fusion protein beyond known RARalpha target genes.
- To identify novel target genes and mechanisms regulated by PML-RARalpha.
- To elucidate the gain-of-function mechanisms of the PML-RARalpha oncoprotein.
Main Methods:
- Analysis of gene expression patterns in response to PML-RARalpha.
- Promoter activity assays for ID1 and ID2 genes.
- Investigation of interactions between PML-RARalpha, Sp1, and NF-Y transcription factors.
Main Results:
- PML-RARalpha activates the ID1 and ID2 gene promoters, a function not observed with wild-type RARalpha/RXR.
- This activation occurs independently of direct DNA binding by PML-RARalpha.
- PML-RARalpha interacts with Sp1 and NF-Y transcription factors to regulate this novel class of target genes.
Conclusions:
- The PML-RARalpha oncoprotein exhibits a gain-of-function by regulating a novel set of target genes, including ID1 and ID2.
- This regulation is mediated through interactions with Sp1 and NF-Y, independent of direct DNA binding.
- These findings offer new insights into the molecular mechanisms of AML pathogenesis and potential therapeutic strategies.
Related Concept Videos
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
RNA Polymerase II Accessory Proteins
Abnormal Proliferation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Co-activators and Co-repressors
The Ras Gene
Ras is a superfamily...

